HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells

References

• Marcus JL, Chao C, Leyden WA, et al. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015;24:1167–1173.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick M, Brooks JT, Kaplan JE. Epidemiology of HIV-associated lung disease in the United States. Semin Respir Crit Care Med. 2016;37:181–198.
   PubMed Web of Science ®Google Scholar
• D’Jaen GA, Pantanowitz L, Bower M, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010;11:396–404.
   PubMed Web of Science ®Google Scholar
• Hessol NA, Martinez-Maza O, Levine AM, et al. Lung cancer incidence and survival among HIV-infected and uninfected women and men. Aids. 2015;29:1183–1193.
   PubMed Web of Science ®Google Scholar
• Vandenhende MA, Roussillon C, Henard S, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000. PloS one. 2015;10:e0129550.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–762.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Pfeiffer RM, Chang L, et al. Elevated risk of lung cancer among people with AIDS. Aids. 2007;21:207–213.
   PubMed Web of Science ®Google Scholar
• Kirk GD, Merlo C, O’driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007;45:103–110.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Cole SR, Mehta SH, et al. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr. 2010;55:510–515.
   PubMed Web of Science ®Google Scholar
• Wistuba II, Behrens C, Milchgrub S, et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998;279:1554–1559.
   PubMed Web of Science ®Google Scholar
• Borges AH, Silverberg MJ, Wentworth D, et al. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. Aids. 2013;27:1433–1441.
   PubMed Web of Science ®Google Scholar
• Staitieh B, Guidot DM. Noninfectious pulmonary complications of human immunodeficiency virus infection. Am J Med Sci. 2014;348:502–511.
   PubMed Web of Science ®Google Scholar
• Almodovar S, Knight R, Allshouse AA, et al. Human immunodeficiency virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses. 2012;28:607–618.
   PubMed Web of Science ®Google Scholar
• Witkowski W, Verhasselt B. Contributions of HIV-1 Nef to immune dysregulation in HIV-infected patients: a therapeutic target? Expert Opin Ther Targets. 2013;17:1345–1356.
   PubMed Web of Science ®Google Scholar
• Landi A, Iannucci V, Nuffel AV, et al. One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. Curr HIV Res. 2011;9:496–504.
   PubMed Web of Science ®Google Scholar
• Marecki JC, Cool CD, Parr JE, et al. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med. 2006;174:437–445.
   PubMed Web of Science ®Google Scholar
• Almodovar S, Hsue PY, Morelli J, et al. Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc Am Thorac Soc. 2011;8:308–312.
   PubMedGoogle Scholar
• Hanna Z, Priceputu E, Hu C, et al. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice. Virology. 2006;346:40–52.
   PubMed Web of Science ®Google Scholar
• Zhu X, Guo Y, Yao S, et al. Synergy between Kaposi’s sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene. 2014;33:1986–1996.
   PubMed Web of Science ®Google Scholar
• Briggs SD, Scholtz B, Jacque JM, et al. HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J Biol Chem. 2001;276:25605–25611.
   PubMed Web of Science ®Google Scholar
• Kramer-Hammerle S, Kohleisen B, Hohenadl C, et al. HIV type 1 Nef promotes neoplastic transformation of immortalized neural cells. AIDS Res Hum Retroviruses. 2001;17:597–602.
   PubMed Web of Science ®Google Scholar
• Wolf D, Witte V, Laffert B, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med. 2001;7:1217–1224.
   PubMed Web of Science ®Google Scholar
• Geleziunas R, Xu W, Takeda K, et al. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature. 2001;410:834–838.
   PubMed Web of Science ®Google Scholar
• He JC, Husain M, Sunamoto M, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest. 2004;114:643–651.
   PubMed Web of Science ®Google Scholar
• Chen ZL, Zhao SH, Wang Z, et al. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer. Chin J Cancer. 2011;30:62–68.
   PubMedGoogle Scholar
• Simi L, Andreani M, Davini F, et al. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Lung Cancer. 2004;45:171–179.
   PubMed Web of Science ®Google Scholar
• Sundaram K, Nishimura R, Senn J, et al. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 2007;313:168–178.
   PubMed Web of Science ®Google Scholar
• Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011;585:2087–2099.
   PubMed Web of Science ®Google Scholar
• Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704–714.
   PubMed Web of Science ®Google Scholar
• Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94:715–725.
   PubMed Web of Science ®Google Scholar
• Greenway AL, McPhee DA, Allen K, et al. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol. 2002;76:2692–2702.
   PubMed Web of Science ®Google Scholar
• Gregoire IP, Richetta C, Meyniel-Schicklin L, et al. IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog. 2011;7:e1002422.
   PubMed Web of Science ®Google Scholar
• Rao S, Tortola L, Perlot T, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun. 2014;5:3056.
   PubMed Web of Science ®Google Scholar
• Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene. 2016;36:1619–1630.
   PubMed Web of Science ®Google Scholar
• Gomes LC, Di Benedetto G, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol. 2011;13:589–598.
   PubMed Web of Science ®Google Scholar
• Chou CH, Lin CC, Yang MC, et al. GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PloS one. 2012;7:e49112.
   PubMed Web of Science ®Google Scholar
• Olivetta E, Pietraforte D, Schiavoni I, et al. HIV-1 Nef regulates the release of superoxide anions from human macrophages. Biochem J. 2005;390:591–602.
   PubMed Web of Science ®Google Scholar
• Bonnet S, Archer SL, Allalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007;11:37–51.
   PubMed Web of Science ®Google Scholar
• Aqil M, Naqvi AR, Bano AS, et al. The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference. PloS one. 2013;8:e74472.
   PubMed Web of Science ®Google Scholar
• Houzet L, Yeung ML, de Lame V, et al. MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology. 2008;5:118.
   PubMed Web of Science ®Google Scholar
• Bennasser Y, Le SY, Benkirane M, et al. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity. 2005;22:607–619.
   PubMed Web of Science ®Google Scholar
• Grinberg M, Gilad S, Meiri E, et al. Vaccinia virus infection suppresses the cell microRNA machinery. Arch Virol. 2012;157:1719–1727.
   PubMed Web of Science ®Google Scholar
• Landi MT, Zhao Y, Rotunno M, et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2010;16:430–441.
   PubMed Web of Science ®Google Scholar
• Kumar MS, Lu J, Mercer KL, et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–677.
   PubMed Web of Science ®Google Scholar